Research & Literature

Changing Pattern of Femoral Deformity During Growth in Polyostotic Fibrous Dysplasia of the Bone: An Analysis of 46 Cases.

Ippolito E, Valentini MB, Lala R, et al.

Journal of pediatric orthopedics 2016; (36(5)):488-93 doi:10.1097/BPO.0000000000000473.

Odontoiatric perspectives and osteonecrosis of the jaw as a possible adverse effect of bisphosphonates therapy in fibrous dysplasia and McCune-Albright syndrome.

Tessaris D, Matarazzo P, Lala R, Defabianis P

Journal of pediatric endocrinology & metabolism : JPEM 2016; (29(3)):333-6.

[McCune-Albright syndrome revealed by Blaschko-linear café-au-lait spots on the back].

Jung AJ, Soskin S, Paris F, Lipsker D

Annales de dermatologie et de venereologie 2016; (143(1)):21-6.

Treatment of Peripheral Precocious Puberty.

Schoelwer M, Eugster EA

Endocrine development 2016; (29()):230-9 doi:10.1159/000438895.

Bone-Grafting in Polyostotic Fibrous Dysplasia.

Leet AI, Boyce AM, Ibrahim KA, et al.

The Journal of bone and joint surgery. American volume 2016; (98(3)):211-9 doi:10.2106/JBJS.O.00547.

McCune-Albright syndrome with craniofacial dysplasia: Clinical review and surgical management.

Belsuzarri TA, Araujo JF, Melro CA, et al.

Surgical neurology international 2016; (7(Suppl 6)):S165-9 doi:10.4103/2152-7806.178567.

Surgical Management of Polyostotic Craniofacial Fibrous Dysplasia: Long-Term Outcomes and Predictors for Postoperative Regrowth.

Boyce AM, Burke A, Cutler Peck C, et al.

Plastic and reconstructive surgery 2016; (137(6)):1833-1839 doi:10.1097/PRS.0000000000002151.

Fibrous Dysplasia/McCune-Albright Syndrome: Clinical and Translational Perspectives.

Robinson C, Collins MT, Boyce AM

Current osteoporosis reports 2016; (14(5)):178-86 doi:10.1007/s11914-016-0317-0.

Fibrous dysplasia of bone: craniofacial and dental implications.

Burke AB, Collins MT, Boyce AM

Oral diseases 2017; (23(6)):697-708 doi:10.1111/odi.12563.

Long-term outcomes of letrozole treatment for precocious puberty in girls with McCune-Albright syndrome.

Estrada A, Boyce AM, Brillante BA, et al.

European journal of endocrinology 2016; (175(5)):477-483 doi:10.1530/EJE-16-0526.

Etiology and therapeutic outcomes of children with gonadotropin-independent precocious puberty.

Kang E, Cho JH, Choi JH, Yoo HW

Annals of pediatric endocrinology & metabolism 2016; (21(3)):136-142 doi:10.6065/apem.2016.21.3.136.

Improving patient outcomes in fibrous dysplasia/McCune-Albright syndrome: an international multidisciplinary workshop to inform an international partnership.

Boyce AM, Turner A, Watts L, et al.

Archives of osteoporosis 2017; (12(1)):21 doi:10.1007/s11657-016-0271-6.

Craniofacial fibrous dysplasia: A 10-case series.

Couturier A, Aumaître O, Gilain L, et al.

European annals of otorhinolaryngology, head and neck diseases 2017; (134(4)):229-235 doi:10.1016/j.anorl.2017.02.004.

Optical Coherence Tomography in the Management of Skull Base Fibrous Dysplasia with Optic Nerve Involvement.

Loewenstern J, Hernandez CM, Chadwick C, et al.

World neurosurgery 2018; (109()):e546-e553 doi:10.1016/j.wneu.2017.10.018.

Association of Hearing Loss and Otologic Outcomes With Fibrous Dysplasia.

Boyce AM, Brewer C, DeKlotz TR, et al.

JAMA otolaryngology-- head & neck surgery 2018; (144(2)):102-107 doi:10.1001/jamaoto.2017.2407.

Polyostotic Fibrous Dysplasia With and Without McCune-Albright Syndrome-Clinical Features in a Nordic Pediatric Cohort.

Utriainen P, Valta H, Björnsdottir S, et al.

Frontiers in endocrinology 2018; (9()):96 doi:10.3389/fendo.2018.00096.

Scoliosis in Fibrous Dysplasia/McCune-Albright Syndrome: Factors Associated With Curve Progression and Effects of Bisphosphonates.

Berglund JA, Tella SH, Tuthill KF, et al.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2018; (33(9)):1641-1648 doi:10.1002/jbmr.3446.

Growth hormone-Insulin-like growth factor 1 axis hyperactivity on bone fibrous dysplasia in McCune-Albright Syndrome.

Tessaris D, Boyce AM, Zacharin M, et al.

Clinical endocrinology 2018; (89(1)):56-64 doi:10.1111/cen.13722.

Individualized approach to the surgical management of fibrous dysplasia of the proximal femur.

Majoor BCJ, Leithner A, van de Sande MAJ, et al.

Orphanet journal of rare diseases 2018; (13(1)):72 doi:10.1186/s13023-018-0805-7.

Head and neck manifestations of an undiagnosed McCune-Albright syndrome: clinicopathological description and literature review.

Lecumberri B, Pozo-Kreilinger JJ, Esteban I, et al.

Virchows Archiv : an international journal of pathology 2018; (473(5)):645-648 doi:10.1007/s00428-018-2396-z.

EFFICACY AND SAFETY OF BISPHOSPHONATE THERAPY IN MCCUNE-ALBRIGHT SYNDROME-RELATED POLYOSTOTIC FIBROUS DYSPLASIA: A SINGLE-CENTER EXPERIENCE.

Wang Y, Wang O, Jiang Y, et al.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2019; (25(1)):23-30 doi:10.4158/EP-2018-0328.

Management of precocious puberty in girls with McCune-Albright syndrome using letrozole.

Wang X, Yu Q

Endocrine connections 2018; (7(12)):1424-1431.

Fibrous dysplasia for radiologists: beyond ground glass bone matrix.

Kushchayeva YS, Kushchayev SV, Glushko TY, et al.

Insights into imaging 2018; (9(6)):1035-1056 doi:10.1007/s13244-018-0666-6.

Age-Related Changes and Effects of Bisphosphonates on Bone Turnover and Disease Progression in Fibrous Dysplasia of Bone.

Florenzano P, Pan KS, Brown SM, et al.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2019; (34(4)):653-660 doi:10.1002/jbmr.3649.

Gynecologic and reproductive outcomes in fibrous dysplasia/McCune-Albright syndrome.

Boyce AM, Casey RK, Ovejero Crespo D, et al.

Orphanet journal of rare diseases 2019; (14(1)):90 doi:10.1186/s13023-019-1057-x.

Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium.

Javaid MK, Boyce A, Appelman-Dijkstra N, et al.

Orphanet journal of rare diseases 2019; (14(1)):139 doi:10.1186/s13023-019-1102-9.

Neonatal McCune-Albright Syndrome: A Unique Syndromic Profile With an Unfavorable Outcome.

Corsi A, Cherman N, Donaldson DL, et al.

JBMR plus 2019; (3(8)):e10134 doi:10.1002/jbm4.10134.

FGF23 and Associated Disorders of Phosphate Wasting.

Gohil A, Imel EA

Pediatric endocrinology reviews : PER 2019; (17(1)):17-34 doi:10.17458/per.vol17.2019.gi.fgf23anddisordersphosphate.

Improved Molecular Diagnosis of McCune-Albright Syndrome and Bone Fibrous Dysplasia by Digital PCR.

Elli FM, de Sanctis L, Bergallo M, et al.

Frontiers in genetics 2019; (10()):862 doi:10.3389/fgene.2019.00862.

Fibrous Dysplasia/McCune-Albright Syndrome: A Rare, Mosaic Disease of Gα s Activation.

Boyce AM, Collins MT

Endocrine reviews 2020; (41(2)) doi:10.1210/endrev/bnz011.

Patients With Isolated Craniofacial Dysplasia Report Better Quality of Life Compared With Those With Craniofacial Dysplasia and Extracranial Involvement.

Hagelstein-Rotman M, Genders SW, Andela CD, et al.

Ophthalmic plastic and reconstructive surgery 2020; (36(3)):292-297 doi:10.1097/IOP.0000000000001536.

The Clinical Spectrum of McCune-Albright Syndrome and Its Management.

Spencer T, Pan KS, Collins MT, Boyce AM

Hormone research in paediatrics 2019; (92(6)):347-356 doi:10.1159/000504802.

McCune-Albright syndrome and type 1 diabetes mellitus: a novel presentation.

Chatty P, Khattab A, Marshall I

Annals of the New York Academy of Sciences 2020; (1463(1)):5-8 doi:10.1111/nyas.14310.

GNAS mutated thyroid carcinoma in a patient with Mc Cune Albright syndrome.

Legrand MA, Raverot G, Nicolino M, Chapurlat R

Bone reports 2020; (13()):100299 doi:10.1016/j.bonr.2020.100299.

[Efficacy and safety of letrozole in treatment of McCune-Albright syndrome girls with peripheral precocious puberty].

Xu , Lu W, Wang X, et al.

Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 2020; (49(3)):291-296 doi:10.3785/j.issn.1008-9292.2020.05.02.

Auxological and Endocrinological Features in Children With McCune Albright Syndrome: A Review.

Tufano M, Ciofi D, Amendolea A, Stagi S

Frontiers in endocrinology 2020; (11()):522 doi:10.3389/fendo.2020.00522.

Optic disc edema in fibrous dysplasia/McCune-Albright syndrome: Prevalence, etiologies, and clinical implications.

Raborn LN, Pan KS, FitzGibbon EJ, et al.

Bone 2021; (143()):115661 doi:10.1016/j.bone.2020.115661.

Bisphosphonates for the treatment of fibrous dysplasia of bone.

Chapurlat R, Legrand MA

Bone 2021; (143()):115784 doi:10.1016/j.bone.2020.115784.

Stigma and psychological distress among pediatric participants in the FD/MAS Alliance Patient Registry.

Konradi A

BMC pediatrics 2021; (21(1)):173 doi:10.1186/s12887-021-02647-7.

McCune-Albright syndrome onset with vaginal bleeding.

Van Doan N, Minh Duc N, Kim Ngan V, Van Anh N

BMJ case reports 2021; (14(7)) doi:10.1136/bcr-2021-243401.

[Preliminary results of surgical treatment of fibrous dysplasia of proximal femur in children].

Bian Z, Guo Y, Zhu ZH, et al.

Zhonghua wai ke za zhi [Chinese journal of surgery] 2021; (59(9)):730-736 doi:10.3760/cma.j.cn112139-20210307-00113.

McCune-Albright syndrome, a rare form of precocious puberty: Diagnosis, treatment, and follow-up.

Gryngarten M, Comar H, Arcari A, et al.

Archivos argentinos de pediatria 2021; (119(5)):e420-e427 doi:10.5546/aap.2021.eng.e420.

Fibrous dysplasia patients with and without craniofacial involvement report reduced quality of life inclusive of stigma, depression, and anxiety.

Konradi A

Chronic illness 2022; (18(4)):927-936 doi:10.1177/17423953211049436.

McCune-Albright syndrome - A case report with transmission electron microscopy.

Garcia Neto V, de Almeida HL, Lorea CF, et al.

Anais brasileiros de dermatologia 2022; (97(1)):58-62 doi:10.1016/j.abd.2021.09.002.

Extent of Extraskeletal Manifestations of Fibrous Dysplasia/McCune-Albright Syndrome in Patients with Mazabraud's Syndrome.

Hagelstein-Rotman M, Appelman-Dijkstra NM, Boyce AM, et al.

Calcified tissue international 2022; (110(3)):334-340 doi:10.1007/s00223-021-00918-0.

Delayed Diagnosis of McCune-Albright Syndrome.

Fantahun B, Desta S

Case reports in genetics 2021; (2021()):2999349 doi:10.1155/2021/2999349.

Postoperative thyroid crisis in an 11-year old male with McCune-Albright syndrome and atypical triiodothyronine hyperthyroidism: A case report.

Hu J, Hu C

Medicine 2022; (101(9)):e28928 doi:10.1097/MD.0000000000028928.

Rickets guidance: part II-management.

Haffner D, Leifheit-Nestler M, Grund A, Schnabel D

Pediatric nephrology (Berlin, Germany) 2022; (37(10)):2289-2302 doi:10.1007/s00467-022-05505-5.

Management Strategies of Fibrous Dysplasia Involving the Paranasal Sinus and the Adjacent Skull Base.

Shi LL, Xiong P, Zhen HT

Ear, nose, & throat journal 2025; (104(2)):85-92 doi:10.1177/01455613221088728.

Craniofacial fibrous dysplasia and aneurismal bone cyst in a patient with McCune-Albright syndrome. A case report and review of the literature.

Castro Castro J, Villa Fernández JM, Agulleiro Díaz JP

Neurocirugia 2023; (34(5)):268-272 doi:10.1016/j.neucie.2022.09.002.

Phosphatonins: From Discovery to Therapeutics.

Kritmetapak K, Kumar R

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2023; (29(1)):69-79 doi:10.1016/j.eprac.2022.09.007.

Otalgia revealing McCune-Albright syndrome: A case report.

Sbai AA, Es-Salhi F, Tsen AA, Fahd Elayoubi

Annals of medicine and surgery (2012) 2022; (82()):104706 doi:10.1016/j.amsu.2022.104706.

Hyperthyroidism in McCune-Albright Syndrome - a case report.

Rosinha P, Ramalho D, Rodrigues O, et al.

Journal of pediatric endocrinology & metabolism : JPEM 2023; (36(3)):319-322 doi:10.1515/jpem-2022-0357.

A multidisciplinary care pathway improves quality of life and reduces pain in patients with fibrous dysplasia/McCune-Albright syndrome: a multicenter prospective observational study.

Meier ME, Hagelstein-Rotman M, van de Ven AC, et al.

Orphanet journal of rare diseases 2022; (17(1)):439 doi:10.1186/s13023-022-02588-z.

Case report: Surgical treatment of McCune-Albright syndrome with hyperthyroidism and retrosternal goiter: A case report and literature review.

Xing Z, Tao G, Pan W, et al.

Frontiers in surgery 2022; (9()):921427 doi:10.3389/fsurg.2022.921427.

Frequency of spontaneous osteosarcomatous transformation of craniofacial fibrous dysplasia: a systematic review.

Furmah P, Aminoshariae A, Mupparapu M, Syed AZ

Oral surgery, oral medicine, oral pathology and oral radiology 2023; (135(5)):678-685 doi:10.1016/j.oooo.2022.12.007.

Autonomous growth hormone secretion due to McCune Albright syndrome in paediatric age group: an ominous triad.

Jayant SS, Walia R, Gupta R, et al.

Endocrine 2023; (81(1)):149-159 doi:10.1007/s12020-023-03333-7.

McCune-Albright Syndrome: A Case Report and Review of Literature.

Nicolaides NC, Kontou M, Vasilakis IA, et al.

International journal of molecular sciences 2023; (24(10)) doi:10.3390/ijms24108464.

Clinical course of peripheral precocious puberty in girls due to autonomous ovarian cysts.

Heo S, Shim YS, Lee HS, Hwang JS

Clinical endocrinology 2024; (100(1)):29-35 doi:10.1111/cen.14943.

Lower-limb intramedullary nailing in patients with polyostotic fibrous dysplasia who had a previous unsuccessful treatment. A report of 48 cases.

Ippolito E, Farsetti P, Caterini R, et al.

Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology 2023; (24(1)):35 doi:10.1186/s10195-023-00705-7.

Craniofacial fibrous dysplasia: Systematic review of facial management.

Bouet B, Schlund M, De Massary M, Nicot R

Journal of stomatology, oral and maxillofacial surgery 2023; (124(6 Suppl 2)):101660 doi:10.1016/j.jormas.2023.101660.

Management of RANKL-mediated Disorders With Denosumab in Children and Adolescents: A Global Expert Guidance Document.

Vanderniet JA, Szymczuk V, Högler W, et al.

The Journal of clinical endocrinology and metabolism 2024; (109(5)):1371-1382 doi:10.1210/clinem/dgad657.

Pasireotide: potential treatment option for McCune-Albright-associated acromegaly.

Ilie MD, Raverot G, Brac de la Perrière A

European journal of endocrinology 2024; (190(1)):K17-K20 doi:10.1093/ejendo/lvad173.

Choosing the Best Tissue and Technique to Detect Mosaicism in Fibrous Dysplasia/McCune-Albright Syndrome (FD/MAS).

Vado Y, Manero-Azua A, Pereda A, Perez de Nanclares G

Genes 2024; (15(1)) doi:10.3390/genes15010120.

Diagnostic journey for individuals with fibrous dysplasia / McCune albright syndrome (FD/MAS).

Song K, Shrestha R, Delaney H, et al.

Orphanet journal of rare diseases 2024; (19(1)):50 doi:10.1186/s13023-024-03036-w.

[Fibrous dysplasia].

Waltermann A, Westhoff B

Orthopadie (Heidelberg, Germany) 2024; (53(10)):805-816 doi:10.1007/s00132-024-04548-w.

A Qualitative Approach to Quality of Life in Fibrous Bone Dysplasia /McCune Albright Syndrome: Looking Beyond Quantitative Analysis.

Jousse J, Merle B, Feurer E, et al.

Calcified tissue international 2025; (116(1)):18 doi:10.1007/s00223-024-01332-y.

A narrative review of the literature on the pediatric orthopedic management of fibrous dysplasia.

Paris E, De Marco G, Vazquez O, et al.

Frontiers in pediatrics 2024; (12()):1502262 doi:10.3389/fped.2024.1502262.

Clinical spectrum and uncommon features of McCune-Albright syndrome in children: a cohort study from a National Referral Center.

Bergignat S, Chapurlat R, Nicolino M, Perge K

Frontiers in endocrinology 2025; (16()):1531765 doi:10.3389/fendo.2025.1531765.

Burosumab treatment of a child with McCune-Albright syndrome/polyostotic fibrous dysplasia: challenges and benefits.

Sakka SD, Georgakopoulou D, Doulgeraki A, et al.

JBMR plus 2025; (9(5)):ziaf042 doi:10.1093/jbmrpl/ziaf042.

Developing a Standardised Dataset for Natural History Studies in Fibrous Dysplasia/McCune-Albright Syndrome.

Priego Zurita AL, Bulaicon OO, Bryce J, et al.

Calcified tissue international 2025; (116(1)):68 doi:10.1007/s00223-025-01379-5.

Peripheral precocious puberty in girls with McCune-Albright syndrome: a case series.

Faria AG, Montenegro LR, Jorge AAL, et al.

Archives of endocrinology and metabolism 2025; (69(2)):e240459 doi:10.20945/2359-4292-2024-0459.

Surgical treatment of monostotic fibrous dysplasia of the proximal femur in children and adolescents: Observational European Paediatric Orthopaedic Society multicenter study.

van Geloven TP, de Witte PB, Laitinen MK, et al.

Journal of children's orthopaedics 2025; 18632521251355884 doi:10.1177/18632521251355884.

Fibrous dysplasia/McCune-Albright syndrome: state-of-the-art advances, pathogenesis, and basic/translational research.

Palmisano B, Berry C, Boyce A, et al.

Orphanet journal of rare diseases 2025; (20(1)):414 doi:10.1186/s13023-025-03909-8.

Early Manifestation of McCune-Albright Syndrome in a 32-Month-Old Female: A Rare Case Report.

Makhlouf TZ, Mahareeq MS, Abumazen A, et al.

Journal of investigative medicine high impact case reports 2025; (13()):23247096251367692 doi:10.1177/23247096251367692.

[Malignancy of fibrous dysplasia of the calvarial bone in patient with McCune-Albright syndrome: clinical observation and literature review].

Rakityanskiy MM, Vinogradov EV, Pronin IN, et al.

Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko 2025; (89(4)):87-97 doi:10.17116/neiro20258904187.

Bisphosphonate therapy in pediatric fibrous dysplasia: A systematic review of clinical, biochemical, and radiological outcomes.

Regmi A, Niraula BB

Journal of clinical orthopaedics and trauma 2025; (70()):103182 doi:10.1016/j.jcot.2025.103182.

Long-Term Follow-Up of a Patient with McCune-Albright Syndrome: A Case Report.

Shoji Y, Kusaka S, Kawashima K, et al.

Journal of clinical medicine 2025; (14(17)) doi:10.3390/jcm14176101.

Childhood fibrous dysplasia.

Pfirrmann C, Journeau P, Chotel F, Chapurlat R

Orthopaedics & traumatology, surgery & research : OTSR 2026; (112(1S)):104440 doi:10.1016/j.otsr.2025.104440.

The Natural Course of Pain in Fibrous Dysplasia/McCune Albright Syndrome: A Prospective Follow Up Study.

Bulaicon OO, Hagelstein-Rotman M, Meier ME, et al.

Calcified tissue international 2025; (116(1)):140 doi:10.1007/s00223-025-01452-z.

Osteosarcomatous Transformation of Long-Standing Fibrous Dysplasia of the Maxilla.

Schwind WN, Brereton CB, Carrau RL, Cho RI

Ophthalmic plastic and reconstructive surgery 2026; (42(5)):e219-e223 doi:10.1097/IOP.0000000000003163.

A phase 2 trial of burosumab for treatment of fibroblast growth factor-23 mediated hypophosphatemia in children and adults with fibrous dysplasia.

de Jong O, Gun ZH, Asante-Otoo A, et al.

medRxiv : the preprint server for health sciences 2025; doi:10.1101/2025.09.26.25334161.

McCune-Albright Syndrome: A Case Series.

Agarwal V, Das S, Chappalagavi AS, et al.

Cureus 2026; (18(1)):e101120 doi:10.7759/cureus.101120.

Denosumab in pediatric patients with fibrous dysplasia/McCune-Albright syndrome: a single-center, open-labeled study.

Ouyang Q, Jiajue R, Zhou R, et al.

Frontiers in endocrinology 2026; (17()):1762370 doi:10.3389/fendo.2026.1762370.

Efficacy of Denosumab for Treatment of Pain in Fibrous Dysplasia and McCune-Albright Syndrome: A Systematic Review.

Yau V, Best DL

Clinical endocrinology 2026; (105(2)):141-150 doi:10.1111/cen.70133.

Genotype-phenotype correlation and challenges in mutation detection in McCune-Albright syndrome: A retrospective study of a French cohort.

Giannetti C, Aouchiche K, Lagarde A, et al.

Annales d'endocrinologie 2026; (87(2)):102514 doi:10.1016/j.ando.2026.102514.

Fibrous dysplasia: Clinical features, deformities, management, and outcomes.

Karaca MO, Özyıldıran M, Kalem M, et al.

Joint diseases and related surgery 2026; (37(2)):531-542.

Multidisciplinary approach and clinical management of McCune-Albright syndrome.

Wang J, Sang Y

Frontiers in endocrinology 2026; (17()):1786683 doi:10.3389/fendo.2026.1786683.

Burosumab use in fibroblast growth factor-23-mediated hypophosphatemia in McCune-Albright syndrome/fibrous dysplasia.

Alsayed Hasan M, Al Mukaddam M

JCEM case reports 2026; (4(6)):luag086 doi:10.1210/jcemcr/luag086.

Genotype-phenotype correlation and challenges in mutation detection in McCune-Albright syndrome: A retrospective study of a French cohort.

Giannetti C, Aouchiche K, Lagarde A, et al.

Annales d'endocrinologie 2026; (87(3)):102556 doi:10.1016/j.ando.2026.102556.

Imaging of Fibrous Dysplasia: A Comprehensive In-Depth Analysis of Monostotic, Polyostotic, Syndromic Forms, and Bone Sarcoma Development.

Spinnato P, Marrone N, Romeo D, et al.

Journal of imaging 2026; (12(6)) doi:10.3390/jimaging12060241.

Individualized antiresorptive therapy in fibrous dysplasia and McCune-Albright syndrome: A retrospective cohort study.

Lipkow T, Bartosik M, Sprick-Schütte J, et al.

Bone reports 2026; (30()):101933 doi:10.1016/j.bonr.2026.101933.

Intensive, interdisciplinary pain treatment in fibrous dysplasia/McCune-Albright syndrome.

Berry C, Randall E, Shulman J, et al.

JBMR plus 2026; (10(8)):ziag107 doi:10.1093/jbmrpl/ziag107.

Orthopaedic diagnostic pitfalls in fibroblast growth factor 23-mediated hypophosphatemic rickets/osteomalacia in fibrous dysplasia/McCune-Albright syndrome: Two burosumab-treated cases.

Nakagawa T, Imanishi J, Koda A, et al.

Bone reports 2026; (30()):101945 doi:10.1016/j.bonr.2026.101945.